Mohammad Hossein Pourhanifeh | Biochemistry | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Mohammad Hossein Pourhanifeh
Kashan University of Medical Sciences, Iran

Mohammad Hossein Pourhanifeh
Affiliation Kashan University of Medical Sciences
Country Iran
Scopus ID 57205343272
Documents 63
Citations 3,730
h-index 34
Subject Area Biochemistry
Event International Popular Scientist Awards
ORCID 0000-0002-6752-2765

Mohammad Hossein Pourhanifeh is a researcher affiliated with Kashan University of Medical Sciences whose scholarly record is associated with biochemistry and biomedical research. His documented publication portfolio includes research and review articles addressing melatonin, cancer biology, oxidative stress, inflammation, apoptosis, autophagy, non-coding RNAs, angiogenesis, and therapeutic approaches to disease. His reported Scopus record comprises 63 documents, 3,730 citations, and an h-index of 34, providing a bibliometric basis for consideration within the Best Researcher Award category.[1] [2] [3]

Abstract

The Best Researcher Award profile for Mohammad Hossein Pourhanifeh summarizes a scholarly record centered on biomedical and biochemical research. His documented work encompasses mechanistic reviews and therapeutic investigations involving melatonin, cancer-associated signaling, oxidative stress, inflammation, apoptosis, autophagy, angiogenesis, and disease progression. His publications include studies addressing lymphoma, melanoma, neuroblastoma, glioblastoma, multiple myeloma, intervertebral disc degeneration, COVID-19 therapeutics, and diabetes-related research. [1] [4] The supplied bibliometric profile reports 63 indexed documents, 3,730 citations, and an h-index of 34.

Keywords

Mohammad Hossein Pourhanifeh; Best Researcher Award; Kashan University of Medical Sciences; Biochemistry; biomedical research; melatonin; cancer biology; oxidative stress; apoptosis; autophagy; angiogenesis; therapeutic research; molecular biology; pharmacology.

Introduction

Biomedical research frequently integrates biochemical mechanisms with clinical and translational questions. Within this context, research on melatonin has attracted attention because of its reported relationships with oxidative stress, inflammatory signaling, programmed cell death, autophagy, angiogenesis, and cellular responses associated with cancer and tissue injury. Pourhanifeh’s publication record includes multiple reviews examining these mechanisms across different disease models and therapeutic contexts. [2]

Research Profile

Mohammad Hossein Pourhanifeh is identified in the supplied academic information as being affiliated with Kashan University of Medical Sciences in Iran and working within the subject area of biochemistry. The profile is associated with Scopus Author ID 57205343272 and ORCID 0000-0002-6752-2765. The reported bibliometric indicators are 63 documents, 3,730 citations, and an h-index of 34. These figures are presented as the supplied profile data and may change as bibliographic databases are updated.

Research Contributions

A prominent component of the supplied research record is the investigation of melatonin as a potential therapeutic or mechanistic agent. The 2022 review on lymphoma examines current evidence concerning melatonin in the context of lymphoma treatment, while related publications consider melanoma, neuroblastoma, and degenerative intervertebral disc disease. [1] [2]

Publications

The following selected publications are drawn from the supplied bibliographic record. DOI links are provided for direct identification of the corresponding articles.

  1. Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence. Fundamental & Clinical Pharmacology (2022).
  2. Anti-degenerative effect of melatonin on intervertebral disc: protective contribution against inflammation, oxidative stress, apoptosis, and autophagy. Current Drug Targets (2022).
  3. RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomedicine & Pharmacotherapy (2021).
  4. Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review. Current Cancer Therapy Reviews (2021).
  5. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology (2021).

Research Impact

The supplied bibliometric profile reports 3,730 citations and an h-index of 34 across 63 documents. These indicators provide quantitative measures of the visibility and citation activity associated with the researcher’s indexed publication record. Bibliometric measures should be interpreted in relation to field, publication age, database coverage, collaboration patterns, and citation practices rather than as standalone measures of research quality.

Award Suitability

The Best Researcher Award recognizes scholarly activity that can be evaluated through research output, subject-matter contribution, publication record, citation indicators, and relevance to an academic field. Based on the supplied information, Pourhanifeh’s profile presents several characteristics that are pertinent to such an assessment, including a substantial indexed publication record, a reported h-index of 34, and 3,730 citations.

Conclusion

Mohammad Hossein Pourhanifeh’s supplied academic profile reflects a research program focused on biochemistry and biomedical questions, with particular emphasis on melatonin, cancer biology, cellular stress mechanisms, inflammation, apoptosis, autophagy, angiogenesis, and therapeutic development. His publication record includes reviews and research contributions addressing a range of diseases and therapeutic candidates. [1]

References

  1. Moradian, F.; Pourhanifeh, M. H.; Mehrzadi, S.; Karimi-Behnagh, A.; Hosseinzadeh, A. (2022). Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence. Fundamental & Clinical Pharmacology.
    DOI: https://doi.org/10.1111/fcp.12780
  2. Pourhanifeh, M. H. (2022). Anti-degenerative effect of melatonin on intervertebral disc: protective contribution against inflammation, oxidative stress, apoptosis, and autophagy. Current Drug Targets.
    DOI: https://doi.org/10.2174/1389450123666220114151654
  3. Pourhanifeh, M. H. (2021). RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomedicine & Pharmacotherapy.
    DOI: https://doi.org/10.1016/j.biopha.2021.112517
  4. Pourhanifeh, M. H. (2021). Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review. Current Cancer Therapy Reviews.
    DOI: https://doi.org/10.2174/1573394717666210526140950
  5. Pourhanifeh, M. H. (2021). Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology.
    DOI: https://doi.org/10.3389/fcell.2021.716462

Palash Mandal | Biochemistry | Best Researcher Award

Published on by International Popular Scientist Awards

Prof. Palash Mandal | Biochemistry | Best Researcher Award

Professor | Charusat | India

Prof. Palash Mandal is a Professor of Biological Sciences at the P. D. Patel Institute of Applied Sciences, CHARUSAT University. His research primarily focuses on the molecular and cellular mechanisms underlying liver diseases, with particular emphasis on alcoholic and nonalcoholic fatty liver disorders. He investigates oxidative stress, inflammation, gut microbiota modulation, and toll-like receptor signaling to identify potential therapeutic targets for hepatic inflammation and fibrosis. His work also explores the role of cytokines, innate immunity, and apoptosis in liver pathology, as well as the development of biomarkers and proteomic profiling for liver diseases. In addition, his research extends to studying metabolic disorders such as obesity and diabetes, especially their interplay with liver dysfunction. Prof. Mandal has published extensively in high-impact journals, contributing to advancements in hepatology, molecular biosciences, and inflammation biology. He has been actively involved in several funded research projects supported by national science agencies and has supervised numerous PhD and postgraduate students. Beyond research, he holds significant editorial responsibilities as Associate or Academic Editor for several international journals, including Frontiers in Gastroenterology, PLOS ONE, Mediators of Inflammation, and Discovery Applied Sciences. His professional affiliations span leading scientific societies such as the Society for Leukocyte Biology, the International Society for Hepatic Sinusoidal Research, and the Indian National Association for the Study of the Liver. Prof. Mandal’s scientific contributions bridge fundamental biology and clinical relevance, aiming to develop innovative therapeutic strategies for liver-related and metabolic diseases.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Gori, P. V., Raval, M., Patel, S., Patel, A., Solanki, N., Patel, P., Nandpal, M., Mandal, P., & Aghara, H. (2025, December). Argyreia nervosa (Brum.f.) Bojer. alleviates diabetes mellitus-induced male infertility. Molecular Biology Reports.

Sonavane, B., Chadha, P., Andhare, P., Dube, S., Singh, N. K., Mandal, P., Amin, S., & Madamwar, D. (2025, November). Phycoerythrin from Aulosira fertilissima: A bioactive macromolecule for longevity and neuroprotection in SH-SY5Y cells and Caenorhabditis elegans. Biocatalysis and Agricultural Biotechnology.

Sharma, D., Vaishnav, B. S., Pandey, N., & Mandal, P. (2025, September 30). Hepatic steatosis: Associated rs2954029 and rs2605100 genetic factors in an Indian population. Discover Applied Sciences.

Chadha, P., Aghara, H., Johnson, D., Sharma, D., Odedara, M., Patel, M., Kumar, H., Thiruvenkatam, V., & Mandal, P. (2025, July). Gardenin A alleviates alcohol-induced oxidative stress and inflammation in HepG2 and Caco2 cells via AMPK/Nrf2 pathway. Bioorganic Chemistry.

Aghara, H., Samanta, S., Patel, M., Chadha, P., Patel, D., Jha, A., & Mandal, P. (2025, July 9). Silver nanoparticles synthesized from Enicostemma littorale exhibit gut tight junction restoration and hepatoprotective activity via regulation of the inflammatory pathway. Pharmaceutics, 17(7), 895.